Anemia Drug Aranesp Considered Safe Before Dialysis

Amgen's anemia drug Aranesp was linked to an increase in strokes in a study of kidney patients last year, prompting the company to include a warning in its prescription notes. This badly affected its sales and general use, as you can imagine. But recently the USA's Food and Drug Administration had a panel of outside advisers vote on whether or not it should continue to be used, and decided that